Association between social vulnerability and clinical outcomes after proximal aortic surgery.
Academic Article
Overview
abstract
OBJECTIVE: To evaluate the relationship between social vulnerability and proximal aortic surgery outcomes. METHODS: Single-center, social vulnerability index (SVI)-stratified, cohort study including all patients undergoing primary proximal aortic surgery from 1997-2023. SVI was calculated by patient residential Zone Improvement Plan (ZIP) code. Outcomes of interest were postoperative major adverse events (operative mortality, myocardial infarction, stroke, reoperation, hemodialysis, tracheostomy) and all-cause mortality at time of last registry assessment. RESULTS: Of 2002 patients, 659 (32.9%) had SVI <0.25, 727 (36.3%) had SVI 0.25-<0.50, 338 (16.9%) had SVI 0.50-<0.75, and 278 (13.9%) had SVI ≥0.75. Patients with SVI ≥0.75 had more comorbidity (diabetes, smoking, chronic obstructive pulmonary disease, prior stroke, renal insufficiency, New York Heart Association class III-IV heart failure), as well as more dissection at presentation and non-elective surgery, compared with lower-SVI patients. Operative mortality occurred in 8/2002 (0.40%) patients and the composite of major adverse events occurred in 99/2002 (4.9%) patients. On multivariable analysis SVI was not significantly associated with major adverse events (odds ratio for SVI ≥0.75: 1.09, 95% confidence interval [CI] 0.56-2.06; p = 0.80). At median follow-up of 8.3 years (95% CI 4.3-14.0), 204 (10.2%) patients had died; patients with SVI ≥0.75 had the highest all-cause mortality (SVI <0.25: 49/659 [7.4%], SVI 0.25- <0.50: 69/727 [9.5%], SVI 0.50- <0.75: 41/338 [12.1%], SVI ≥0.75: 45/278 [16.2%]; p = 0.001). After multivariable adjustment for confounders, SVI was not significantly associated with all-cause mortality (hazard ratio for SVI ≥0.75: 1.29, 95% CI 0.90-1.85; p = 0.17). CONCLUSION: Preoperative SVI is not independently associated with early or late outcomes after surgery of the proximal aorta, despite the most vulnerable patients having the highest long-term mortality.